Kiran Patel
Institution: Gilead Sciences (United States)
Observed institutions: Northwestern University, University of North Carolina at Chapel Hill, Goethe University Frankfurt, Cincinnati Children's Hospital Medical Center, The University of Sydney, Beth Israel Deaconess Medical Center, The University of Texas MD Anderson Cancer Center, The University of Texas at San Antonio Health Science Center, University of Mannheim, GlaxoSmithKline (United Kingdom), Washington University in St. Louis, Peter MacCallum Cancer Centre, Sir Charles Gairdner Hospital, TUM Klinikum, Westmead Hospital, Sanofi (France), University of California San Diego, University of Colorado Health, University Medical Center of the Johannes Gutenberg University Mainz, Sanofi (United States), GlaxoSmithKline (United States), Dana-Farber Cancer Institute, Melanoma Institute Australia, Methodist Hospital, Gilead Sciences (United States), University Medical Centre Mannheim, Vanderbilt-Ingram Cancer Center, Telik, Inc. (United States), Janssen Research & Development (United States), New York University, University of Cincinnati, Charité – Universitätsmedizin Berlin, Icahn School of Medicine at Mount Sinai
OpenAlex ID: A5111283735